This inventor holds 1 USPTO granted patent. Top assignee: Samsung Electronics Co., Ltd.. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Eon-Kyeom Kim: Innovator in Therapeutic Seleno Compounds
Introduction
Eon-Kyeom Kim is a notable inventor based in Taejon, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel therapeutic compounds. His work focuses on addressing medical dysfunctions and diseases associated with reactive oxygen species.
Latest Patents
Eon-Kyeom Kim holds a patent for "Seleno compounds containing nitrone moiety, their preparation and their therapeutic uses." This invention provides innovative seleno compounds that contain a nitrone moiety. The compounds are designed to treat and prevent various medical conditions, including stroke, Parkinson's disease, and Alzheimer's disease. They exhibit similar or superior lipid peroxidation inhibition activity compared to reference compounds. Additionally, these compounds demonstrate lower toxicity and improved water solubility, effectively inhibiting cerebral neuronal cell death caused by reactive oxygen species and offering neuroprotective effects against ischemic neuronal degeneration.
Career Highlights
Eon-Kyeom Kim is associated with Samsung Electronics Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on therapeutic applications in neurology and other medical fields.
Collaborations
Eon-Kyeom Kim has collaborated with notable colleagues, including Moo-Ho Won and Laura L Dugan. These partnerships have contributed to the advancement of his research and the development of innovative therapeutic solutions.
Conclusion
Eon-Kyeom Kim is a distinguished inventor whose work in therapeutic seleno compounds holds promise for treating serious medical conditions. His contributions to medicinal chemistry are paving the way for future innovations in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
